Instability of Neurological Diagnosis
Discover the data behind diagnostic variability and why we believe biomarkers, including oculomotor ones, could be part of the way forward.
Reliability of Oculomotor Biomarkers
Discover the reliability of oculomotor biomarkers and how consistent eye movement metrics support early detection of neurological disorders
Exploring Anti-Saccades and Frontal Lobe Function
Learn more about how neuroClues® eye movement biomarkers could support early detection of cognitive impairments.
Neural Pathways of Voluntary and Reflexive Saccades
Learn more about the differences between voluntary and reflexive saccades, the structures involved in those movements, and how they can provide interesting clues about brain health.
Oculomotor Biomarkers Recorded on 50 Patients with neuroClues®, now CE-Marked!
Learn more about neuroClues®’ role in the ICEBERG cohort with 50 patients recorded, and how eye movement analysis is advancing cognitive impairment detection.
Reference Oculomotor Ranges in Eye Tracking with NeuroClues
Explore how neuroClues calculates the reference oculomotor ranges in eye tracking, with exclusive insights into the technical details.
Eye Movements: A Key to Supporting Pharmaceutical Research
Explore recent studies on how eye movements can support pharmaceutical research in diagnosing, monitoring, and developing new neurological treatments.
Clinical highlights: Multiple Sclerosis (MS)
The newsletter of this month will emphasize the latest research about Multiple Sclerosis
Clinical highlights: Alzheimer’s Disease (AD)
The newsletter of this month will emphasize the latest research about Alzheimer’s Disease
Clinical highlights: Progressive Supra Nuclear Palsy (PSP)
The newsletter of this month will emphasize the latest research about Progressive Supra Nuclear Palsy (PSP) as May is PSP Awareness month
